Clinical Trial

Early Detection of Prostate Cancer of Syrian Men

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
Prostate cancer is a significant health concern in the Middle East, including Syria, where many cases are diagnosed at advanced stages due to low awareness and inadequate screening practices. The mortality-to-incidence ratio for prostate cancer in the region is alarmingly high, indicating a pressing need for effective early detection strategies.
Trial Details
NCT Number NCT07075666
Lead Sponsor Al-Hawash Private University
Conditions the Detection of Prostate Cancer in Men
Enrollment 1,000 participants
Start Date 2025-05-17
Primary Completion 2025-05-31 (estimated)
Study Completion 2025-07-30 (estimated)
Updated on ClinicalTrials.gov 2025-07-20